Spinal Fusion Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

Market Overview

The spinal fusion devices market is projected to register a CAGR of 3.48% during the forecast period, with a revenue of approximately USD 6,705 million in 2020 and expected to reach USD 8,232 million by 2026.

The COVID-19 pandemic has been continuing to transform the growth of various markets, the immediate impact of the outbreak is varied. While a few industries registered a drop in demand, numerous other markets may continue to remain unscathed and show promising growth opportunities. Initially, the outbreak of COVID-19 worldwide and lockdown situation across some countries have shown some challenges on the market studied, due to hold on orthopedic services by the hospitals and clinics, in order to prevent the spread of COVID-19 virus and in fact, the tremendous pressure on the hospitals in providing services to COVID-19 patients is also one of the factors, which has been inhibiting the hospitals and clinics in providing spine fusion services. According to Ann Med Surg in his article published in 2020, an estimate of the orthopedic surgery cancellation rate was approximately 82.0%, representing 6,295,041 of 7,677,515 cases. They concluded that if countries increased their normal surgical volumes by 20% after the pandemic, it would take about 45 weeks to clear the backlog of operations resulting from the disruption caused by COVID-19.

Moreover, the global population is aging rapidly, owing to the reduced birth rates and increasing life expectancy. The demographic trend toward an aging population represents an increasing need for the management of old age-associated spine disorders. according to the World Ageing 2019 report, in 2019, there were around 703 million population aged 65 years or over in the world. The number of older persons is projected to double to 1.5 billion in 2050. Globally, the share of the population aged 65 years or over increased from 6% in 1990 to 9% in 2019. The proportion is projected to rise further to 16% by 2050. By 2050, 1 in 6 people in the world will be over the age of 65, up from 1 in 11 in 2019.​ These physiological changes, along with prolonged exposure to risk factors, increase the incidence rates of spine disorders, which may require surgical intervention. Hence, the market studied will be majorly driven by the aging population rise and growing spine disorders.

Moreover, as per the Spinal Cord Injuries Australia (SCIA) a non-government organization, approximately 15,000 people in Australia have spinal cord injuries (SCIs) in the year 2020. A total of 227 newly incident cases of traumatic spinal cord injury (SCI) due to external causes were reported to the Australian Spinal Cord Injury Register for 2016–17. The majority (80%) of these were males. Land transport crashes (39%) and falls (39%) were most often reported as the cause of traumatic SCI. Similarly, according to the Spinal Injury Association UK 2019, about 2,500 people are injured or diagnosed with spinal cord injuries every year and an estimated 50,000 people are living with spinal cord injuries in the United Kingdom. Thus the high incidence of spinal cord injuries surges the demand for spinal fusion devices over the coming years. Furthermore the increasing preference for minimally invasive surgeries due to several benefits are also propelling the overall market growth.

Other factors limiting the growth of this market are the stringent regulation associated with spinal devices.

Scope of the Report

As per the scope of this report, spinal fusion refers to an orthopedic procedure that involves the fusion of two or more vertebrae, to restrict the movement of the affected vertebrae and decrease the pain suffered by the patient. The spinal fusion devices market is segmented by Type (Cervical Fusion Device, Thoracic Fusion Device, Lumbar Fusion Device), Type of Surgery (Open Spine Surgery, Minimally Invasive Spine Surgery), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Lumbar Fusion are Expected to Witness Healthy Growth

The outbreak of COVID-19 worldwide showed an impact on the market studied as surgical procedures were kept on hold to prevent the spread of the COVID-19 virus. There is tremendous pressure on hospitals and other healthcare centers in providing services to COVID-19 patients, which is also one of the factors inhibiting the hospitals from providing services. According to the research conducted by the CovidSurg Collaborative, a research network, in August 2020, it was found that orthopedic procedures will be canceled most frequently, with 6.3 million orthopedic surgeries canceled worldwide over a 12-week period​, which may have a short-term negative impact on the market. In addition According to Thirunarayanan V, published in October 2020, outpatient orthopedic services decreased by 75% during the pandemic in India. The percentage of surgeons who operated less than 5 cases per week before the pandemic was 39.4%, which rose to 94.1% during the pandemic. Thus the decline in orthopedic surgeries was observed in the initial period of COVID-pandemic, 

Moreover, lumbar fusion is a complex operation that requires the use of screws that are placed between the vertebrae to be fused. The bone graft is then placed around these screws. The screws that are used during this operation are made of titanium and are usually placed for a lifetime. These operations involve higher risks than simple laminectomies or discectomies. The recovery period is typically longer after this procedure and operating time can be anywhere between four to eight hours. It has been found that developing countries like India are offering advanced medical facilities at the most reasonable costs. For the lumbar fusion surgery, the cost is becoming low, which is acting as a beneficial factor for patients who need lumbar fusion.

There have been significant advancements in the field of minimally invasive lumbar fusions. In June 2020 the company 4WEB Medical had announced the 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Stand-Alone Anterior Lumbar Interbody Fusion Device. The high adoption rates of minimally invasive procedures, such as transforaminal lumbar interbody fusion (TLIF) and posterior lumbar interbody fusion (PLIF), are contributing to the market expansion.

To understand key trends, Download Sample Report